top of page
Soft Round Shapes_edited 4.jpg

Proteins.

Invented by nature,

perfected by Scala.

symbol copy_edited_edited_edited.png
About_fold_bg_edited 5.jpg

ABOUT SCALA

We provide our partners a unique one-shot computational solution to dramatically increase the value and accelerate the development of proteins into commercial products

Nature provides solutions to some of the biggest challenges facing humanity. The pharmaceutical, chemical and sustainability industries are harnessing nature’s molecular machines — enzymes, antibodies, and other proteins — to provide life-saving drugs and environmental-friendly processes that generate the products our societies need.

But natural proteins lack the resilience and specificity that modern medicine and industry require.
We combine evolutionary analysis, atomistic protein design calculations, and AI to design proteins that exhibit superior properties.
Our solution is based on more than a decade of research at the Weizmann Institute of Science and in collaboration with dozens of labs around the world.

Our strategy yielded the first one-shot design approaches to be validated across vaccine immunogens, industrial and therapeutic enzymes, therapeutic antibodies, molecular probes, membrane channels, and more.

ABOUT
PROJECTS

PRODUCTS

PROTEIN STABILITY & EXPRESSION

01

Improve production yields & expression of complex proteins in simple organisms

Increase thermostability

Increase resilience to organic solvents, pH, etc.

Increase shelf life

Reduce aggregation

ENZYME 

ACTIVITY

02

Improve catalytic activity

Increase enzyme specificity

protein1_edited.png
blur copy_edited.png
blur copy_edited.png

PROTEIN-PROTEIN INTERACTIONS 

03

Future Product

Protein affinity engineering

MEMBRANE PROTEINS

04

Future Product

Improve expression & thermostability

ANTIBODY OPTIMIZATION

05

Future Product

Humanization

Stabilization

THE TEAM
Dr. Adi Goldenzweig

Co Founder & CTO

Creative Strategist

THE FOUNDING TEAM

Dr. Adi Goldenzweig

Co-founder & CTO

Dr. Ravit Netzer

Co-founder & CEO

Prof. Sarel Fleishman

Chief Scientist

Our founding team has over a decade of experience developing cutting-edge protein design methods.
We established Scala to elevate protein design to the scale and reliability that are needed by the biotechnology and biopharmaceutical industries.
BACKED BY:
weizmann-logo.png
SADF.png
01-Intel-Ignite-logo-alumni.png
CONTACT

CONTACT

Thanks for submitting!

bottom of page